MICR Micron Solutions Inc

Micron Products, Inc. ("Micron") a wholly owned subsidiary of Arrhythmia Research Technology, Inc. (the "Company") (AMEX: HRT) is pleased to announce the formation of Micron Integrated Technologies ("MIT") specializing in the production of metal and plastic components for the medical and defense industries. Mark LaViolette, Vice President of Sales and Marketing remarked, "We are pleased to announce the formation of MIT and the addition of Mr. Daniel R. White as the Director of Business Development to the Micron sales team. Mr. White brings over twenty years of metal forging, investment casting, and metal machining experience to our expanded production capabilities. His network of international suppliers of various ferrous and non-ferrous metal products compliments the internal and local capabilities of the new MIT division." James E. Rouse, the Company's President and CEO commented, "The expansion of Micron's offerings with this division will better serve our existing customer base and allow for diversification into new markets. We will provide end-to-end product life cycle management through a comprehensive portfolio of value-added services such as design, engineering, prototyping, manufacturing, machining, assembly and packaging. We are very excited about the prospects for growth in the future." The Company, through Micron, manufacturers silver plated and non-silver plated conductive resin sensors and distributes metal snaps used in the manufacture of disposable ECG, EEG, EMS, and TENS electrodes. Micron's NEM division manufactures custom injection molded products for medical, electronic, industrial and consumer applications. The Company's products also include proprietary signal-averaging electrocardiography (SAECG) software used in the detection of potentially lethal heart arrhythmias. Forward-looking statements made herein are based on current expectations of the Company that involve a number of risks and uncertainties and should not be considered as guarantees of future performance. The factors that could cause actual results to differ materially include: interruptions or cancellation of existing contracts, impact of competitive products and pricing, product demand and market acceptance, risks, the presence of competitors with greater financial resources than the Company, product development and commercialization risks, and changing economic conditions in developing countries. More information about factors that potentially could affect the Company's financial results is included in the Company's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-KSB for the year ended December 31, 2004.